Assignee profile:

GlaxoSmithKline, LLC

City:

Wilmington, Delaware

Country:

United States

Published Applications:

96

Last publication date:

2026-06-04

Patent Grants:

85

Last grant date:

2026-03-17

Top Inventors for applications by GlaxoSmithKline, LLC

These are the the leading inventors for applications assigned to GlaxoSmithKline, LLC:

Recent patent applications by GlaxoSmithKline, LLC

GlaxoSmithKline, LLC based in Wilmington, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-06-04
US20260152472A1
Chemistry; metallurgy

Phenyl Amino Pyrimidine Compounds and Uses Thereof

#2 | 2024-10-24 ✅ Patent 12,576,089 granted on 2026-03-17
US20240350507A1
Human necessities

PLATELET COUNT-AGNOSTIC METHODS OF TREATING MYELOFIBROSIS

#3 | 2021-11-11 ✅ Patent 11,643,397 granted on 2023-05-09
US20210347740A1
Chemistry; metallurgy

Prolyl hydroxylase inhibitors

#4 | 2021-09-30 ✅ Patent 11,963,962 granted on 2024-04-23
US20210299132A1
Human necessities

Platelet count-agnostic methods of treating myelofibrosis

#5 | 2020-05-21 ✅ Patent 11,390,671 granted on 2022-07-19
US20200157206A1
Chemistry; metallurgy

Biopharmaceutical compositions and methods for pediatric patients

#6 | 2020-03-05 ✅ Patent 11,325,972 granted on 2022-05-10
US20200071395A1
Chemistry; metallurgy

Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody

#7 | 2019-08-22 ✅ Patent 10,660,898 granted on 2020-05-26
US20190255064A1
Human necessities

Benzimidazole derivatives as PI3 kinase inhibitors

#8 | 2019-05-09 ✅ Patent 10,385,066 granted on 2019-08-20
US20190135829A1
Chemistry; metallurgy

Compounds as diacylglycerol acyltransferase inhibitors

#9 | 2019-01-31
US20190029591A1
Human necessities

METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASS

#10 | 2018-10-25 ✅ Patent 10,336,711 granted on 2019-07-02
US20180305323A1
Chemistry; metallurgy

Prolyl hydroxylase inhibitors

#11 | 2018-09-20 ✅ Patent 10,314,845 granted on 2019-06-11
US20180263994A1
Human necessities

Benzimidazole derivatives as PI3 kinase inhibitors

#12 | 2018-05-03 ✅ Patent 10,117,873 granted on 2018-11-06
US20180117048A1
Human necessities

6-amino-purin-8-one compounds

#13 | 2017-12-28
US20170367648A1
Human necessities

METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASS

#14 | 2017-12-14 ✅ Patent 10,590,135 granted on 2020-03-17
US20170355697A1
Chemistry; metallurgy

Substituted bridged urea analogs as sirtuin modulators

#15 | 2017-10-12 ✅ Patent 10,022,442 granted on 2018-07-17
US20170290910A1
Human necessities

Pyrazolopyrimidine compounds

#16 | 2017-09-21 ✅ Patent 10,391,717 granted on 2019-08-27
US20170266873A1
Performing operations; transporting

Package and heat sealing device

#17 | 2017-06-22 ✅ Patent 9,868,761 granted on 2018-01-16
US20170174721A1
Chemistry; metallurgy

Buffer system for protein purification

#18 | 2017-06-08 ✅ Patent 9,861,627 granted on 2018-01-09
US20170157113A1
Human necessities

4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor

#19 | 2017-04-27 ✅ Patent 9,872,860 granted on 2018-01-23
US20170112844A1
Human necessities

Benzimidazole derivatives as PI3 kinase inhibitors

#20 | 2017-03-23 ✅ Patent 9,907,847 granted on 2018-03-06
US20170080085A1
Human necessities

Pyrrolopyrimidines as therapeutic agents for the treatment of diseases

#21 | 2016-11-03 ✅ Patent 9,610,284 granted on 2017-04-04
US20160317529A1
Human necessities

4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor

#22 | 2016-10-13 ✅ Patent 9,663,533 granted on 2017-05-30
US20160297832A1
Chemistry; metallurgy

Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors

#23 | 2016-10-13 ✅ Patent 10,035,779 granted on 2018-07-31
US20160297772A1
Chemistry; metallurgy

Prolyl hydroxylase inhibitors

#24 | 2016-09-08 ✅ Patent 9,753,034 granted on 2017-09-05
US20160258946A1
Physics

Process for the identification of a compound which inhibits the binding of the first bromodomain of each of human BRD-2, BRD-3, and BRD-4

#25 | 2016-08-11 ✅ Patent 9,877,968 granted on 2018-01-30
US20160228445A1
Human necessities

6-amino-purin-8-one compounds

#26 | 2016-08-04 ✅ Patent 9,737,260 granted on 2017-08-22
US20160220182A1
Human necessities

Methods for determining total body skeletal muscle mass

#27 | 2016-04-21 ✅ Patent 10,010,608 granted on 2018-07-03
US20160106835A1
Human necessities

Combination therapies for cancer

#28 | 2016-04-07 ✅ Patent 9,446,034 granted on 2016-09-20
US20160095841A1
Human necessities

Pyrazolylaminopyridines as inhibitors of FAK

#29 | 2016-03-24 ✅ Patent 9,765,075 granted on 2017-09-19
US20160083386A1
Chemistry; metallurgy

Substituted bridged urea analogs as sirtuin modulators

#30 | 2016-01-21 ✅ Patent 9,926,570 granted on 2018-03-27
US20160017343A1
Chemistry; metallurgy

Host cells and methods of use

#31 | 2015-12-10
US20150352121A1
Human necessities

COMBINATION

#32 | 2015-11-12 ✅ Patent 10,238,678 granted on 2019-03-26
US20150320777A1
Human necessities

Therapeutic methods

#33 | 2015-11-05 ✅ Patent 9,416,130 granted on 2016-08-16
US20150315184A1
Chemistry; metallurgy

4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor

#34 | 2015-11-05 ✅ Patent 9,795,619 granted on 2017-10-24
US20150313917A1
Human necessities

Pharmaceutical compositions

#35 | 2015-10-22 ✅ Patent 9,428,512 granted on 2016-08-30
US20150299204A1
Chemistry; metallurgy

Compounds

#36 | 2015-10-08 ✅ Patent 9,540,383 granted on 2017-01-10
US20150284396A1
Chemistry; metallurgy

Pyrrolopyrimidines as therapeutic agents for the treatment of diseases

#37 | 2015-09-24 ✅ Patent 9,550,785 granted on 2017-01-24
US20150266883A1
Chemistry; metallurgy

Pyrrolopyrimidines as therapeutic agents for the treatment of diseases

#38 | 2015-09-03 ✅ Patent 9,156,797 granted on 2015-10-13
US20150246889A1
Chemistry; metallurgy

Benzimidazole derivatives as PI3 kinase inhibitors

#39 | 2015-08-13 ✅ Patent 9,555,036 granted on 2017-01-31
US20150225403A1
Chemistry; metallurgy

Pyrazolopyrimidine compounds

#40 | 2015-07-02 ✅ Patent 9,227,914 granted on 2016-01-05
US20150183723A1
Chemistry; metallurgy

Calcilytic compounds

#41 | 2015-06-04 ✅ Patent 9,834,558 granted on 2017-12-05
US20150152108A1
Chemistry; metallurgy

Substituted bridged urea analogs as sirtuin modulators

#42 | 2015-05-21 ✅ Patent 9,114,141 granted on 2015-08-25
US20150141436A1
Human necessities

Indoles

#43 | 2015-04-23 ✅ Patent 9,605,058 granted on 2017-03-28
US20150110810A1
Chemistry; metallurgy

Antibodies against the CXC-ELR family of chemokines

#44 | 2015-04-02
US20150094321A1
Human necessities

COMBINATION

#45 | 2015-03-19
US20150079030A1
Chemistry; metallurgy

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)

#46 | 2015-01-01 ✅ Patent 9,901,479 granted on 2018-02-27
US20150005812A1
Human necessities

External nasal dilator and methods

#47 | 2014-12-25 ✅ Patent 9,062,003 granted on 2015-06-23
US20140378456A1
Chemistry; metallurgy

Benzimidazole derivatives as PI3 kinase inhibitors

#48 | 2014-11-27 ✅ Patent 9,340,513 granted on 2016-05-17
US20140350032A1
Chemistry; metallurgy

Propenoate derivatives of betulin

#49 | 2014-11-27 ✅ Patent 9,957,271 granted on 2018-05-01
US20140349993A1
Chemistry; metallurgy

Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators

#50 | 2014-11-13 ✅ Patent 9,233,962 granted on 2016-01-12
US20140336175A1
Chemistry; metallurgy

Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases

#51 | 2014-09-25 ✅ Patent 10,112,946 granted on 2018-10-30
US20140288099A1
Chemistry; metallurgy

Composition

#52 | 2014-09-18
US20140275107A1
Human necessities

CANCER TREATMENT METHOD

#53 | 2014-09-04
US20140249147A1
Human necessities

Substituted Bicyclic Aza-Heterocycles and Analogues as Sirtuin Modulators

#54 | 2014-08-14
US20140228288A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#55 | 2014-08-14
US20140228284A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#56 | 2014-07-31 ✅ Patent 9,119,868 granted on 2015-09-01
US20140212384A1
Human necessities

Therapeutic methods

#57 | 2014-07-03 ✅ Patent 9,096,605 granted on 2015-08-04
US20140187545A1
Chemistry; metallurgy

Pyrazolopyrimidine derivatives as PI3 kinase inhibitors

#58 | 2014-06-19 ✅ Patent 9,067,936 granted on 2015-06-30
US20140171462A1
Chemistry; metallurgy

4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor

#59 | 2014-06-05
US20140155410A1
Chemistry; metallurgy

PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK

#60 | 2014-05-29 ✅ Patent 9,796,729 granted on 2017-10-24
US20140148437A1
Chemistry; metallurgy

Compounds as diacylglycerol acyltransferase inhibitors

#61 | 2014-04-17 ✅ Patent 9,012,479 granted on 2015-04-21
US20140107131A1
Chemistry; metallurgy

Pyrazolylaminopyridines as inhibitors of FAK

#62 | 2014-04-10 ✅ Patent 8,785,433 granted on 2014-07-22
US20140100234A1
Chemistry; metallurgy

Quinoline derivatives as PI3 kinase inhibitors

#63 | 2014-04-10 ✅ Patent 9,340,529 granted on 2016-05-17
US20140100213A1
Chemistry; metallurgy

Triazolones as fatty acid synthase inhibitors

#64 | 2014-02-27 ✅ Patent 8,980,950 granted on 2015-03-17
US20140057980A1
Chemistry; metallurgy

Calcilytic compounds

#65 | 2014-02-27 ✅ Patent 9,173,872 granted on 2015-11-03
US20140056928A1
Human necessities

Pyrazolopyrimidine compounds

#66 | 2014-02-13 ✅ Patent 10,286,037 granted on 2019-05-14
US20140044717A1
Human necessities

Methods of producing lyophilized polypeptide composition formulations comprising volatile additives

#67 | 2014-02-06 ✅ Patent 8,846,024 granted on 2014-09-30
US20140037580A1
Chemistry; metallurgy

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#68 | 2014-01-16 ✅ Patent 9,624,261 granted on 2017-04-18
US20140018525A1
Chemistry; metallurgy

Buffer system for protein purification

#69 | 2013-10-31 ✅ Patent 8,940,772 granted on 2015-01-27
US20130289079A1
Human necessities

Nicotine lozenge composition

#70 | 2013-09-05 ✅ Patent 8,946,278 granted on 2015-02-03
US20130231378A1
Chemistry; metallurgy

Inhibitors of AkT activity

#71 | 2013-07-18 ✅ Patent 9,102,685 granted on 2015-08-11
US20130184263A1
Chemistry; metallurgy

Derivatives of betulin

#72 | 2013-03-28 ✅ Patent 9,085,582 granted on 2015-07-21
US20130079335A1
Chemistry; metallurgy

Benzotriazolodiazepine compounds inhibitors of bromodomains

#73 | 2013-02-28 ✅ Patent 8,691,763 granted on 2014-04-08
US20130053317A1
Human necessities

Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection

#74 | 2012-12-13 ✅ Patent 8,802,864 granted on 2014-08-12
US20120316151A1
Chemistry; metallurgy

Triazolones as fatty acid synthase inhibitors

#75 | 2012-10-04 ✅ Patent 9,102,677 granted on 2015-08-11
US20120252781A1
Chemistry; metallurgy

Benzodiazepine bromodomain inhibitor

#76 | 2012-10-04 ✅ Patent 9,556,201 granted on 2017-01-31
US20120252780A1
Chemistry; metallurgy

Bicyclic pyridines and analogs as sirtuin modulators

#77 | 2012-08-09 ✅ Patent 8,796,298 granted on 2014-08-05
US20120202835A1
Human necessities

Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer

#78 | 2012-08-02 ✅ Patent 8,835,450 granted on 2014-09-16
US20120196886A1
Human necessities

Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer

#79 | 2012-07-05 ✅ Patent 9,642,995 granted on 2017-05-09
US20120172923A1
Human necessities

External nasal dilator

#80 | 2012-06-07 ✅ Patent 10,392,625 granted on 2019-08-27
US20120142895A1
Chemistry; metallurgy

Host cells and methods of use

#81 | 2012-04-19 ✅ Patent 8,828,430 granted on 2014-09-09
US20120093927A1
Human necessities

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

#82 | 2012-02-09 ✅ Patent 9,346,806 granted on 2016-05-24
US20120035193A1
Human necessities

6-amino-purin-8-one compounds

#83 | 2011-12-15 ✅ Patent 9,326,986 granted on 2016-05-03
US20110306612A1
Human necessities

Quinazolinone, quinolone and related analogs as sirtuin modulators

#84 | 2011-12-08 ✅ Patent 8,673,948 granted on 2014-03-18
US20110301203A1
Chemistry; metallurgy

Chemical compounds

#85 | 2011-11-10 ✅ Patent 8,697,685 granted on 2014-04-15
US20110275611A1
Chemistry; metallurgy

Chemical compounds

#86 | 2011-10-13 ✅ Patent 9,163,024 granted on 2015-10-20
US20110251218A1
Human necessities

Tris salts of 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione

#87 | 2011-05-26 ✅ Patent 8,846,947 granted on 2014-09-30
US20110124637A1
Chemistry; metallurgy

Benzimidazoles and related analogs as sirtuin modulators

#88 | 2011-05-19 ✅ Patent 9,163,052 granted on 2015-10-20
US20110118203A1
Chemistry; metallurgy

Crystalline forms of an antiviral benzimidazole compound

#89 | 2011-03-03 ✅ Patent 8,834,511 granted on 2014-09-16
US20110054517A1
Human necessities

External nasal dilator and methods of manufacture

#90 | 2011-02-24 ✅ Patent 8,685,970 granted on 2014-04-01
US20110046110A1
Chemistry; metallurgy

Quinolines and related analogs as sirtuin modulators

#91 | 2011-01-27 ✅ Patent 9,834,600 granted on 2017-12-05
US20110020339A1
Chemistry; metallurgy

Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody

#92 | 2010-08-19 ✅ Patent 8,835,381 granted on 2014-09-16
US20100210470A1
Physics

Methods for detecting protein in plasma

#93 | 2010-01-14 ✅ Patent 8,871,800 granted on 2014-10-28
US20100010026A1
Human necessities

Statin and omega-3 fatty acids for reduction of Apo-B levels

#94 | 2009-05-21 ✅ Patent 9,107,856 granted on 2015-08-18
US20090130032A1
Human necessities

Dental appliance cleanser

#95 | 2007-09-13 ✅ Patent 8,784,886 granted on 2014-07-22
US20070212411A1
Human necessities

Coating capsules with active pharmaceutical ingredients

#96 | 2006-09-07 ✅ Patent 9,675,548 granted on 2017-06-13
US20060198873A1
Human necessities

Orally dissolving films

Also check out GLAXOSMITHKLINE LLC's (Wilmington, United States) applicant profile with 44 patent applications submitted.

AssigneeID:

56589 ⎘